Meeting
2022 ASCO Annual Meeting
Longitudinal screening for depression and anxiety in prostate cancer (PC) and association with disease and treatment factors.
Authors
Risa Liang Wong
Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA
Risa Liang Wong , Heather H. Cheng , Jesse R. Fann , James Hnida , Marty Chakoian , Yael Schenker , Evan Y. Yu , John L. Gore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5023)
DOI
10.1200/JCO.2022.40.16_suppl.5023
Abstract #
5023
Poster Bd #
207
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Depression, anxiety, and patterns of mental health care among men with prostate cancer on androgen deprivation therapy (ADT).
First Author: Phoebe A. Tsao
Poster
2017 Genitourinary Cancers Symposium
The association of androgen deprivation therapy and anxiety among 78,000 patients with localized prostate cancer patients.
First Author: Kathryn T Dinh
Poster
2024 ASCO Annual Meeting
Independent blinded validation of an AI-based digital histology classifier for prostate cancer recurrence and metastasis risk prediction.
First Author: Magdalena Fay
Poster
2024 ASCO Genitourinary Cancers Symposium
Racial and ethnic differences in the receipt of metabolic syndrome risk factor screening and treatment among individuals with prostate cancer treated with androgen deprivation therapy.
First Author: Yazan K. Barqawi